Environmental Health Perspectives · 2023 · 29 citations · 45 references
MedicineEndocrinologyToxicologyPediatric EndocrinologyReproductive EndocrinologyReproductive PhysiologyAndrogen PhysiologyEndocrine AssessmentEndocrine ToxicityGonadal ToxicologyHormonal InfluencesPubertyDevelopmental Exposure To Endocrine-disrupting ChemicalsEndocrine Disrupting CompoundsEndocrine-disrupting Chemical EffectsHormonal Biomarkers Of PubertyHormonal Markers Of PubertyPerfluoroalkyl Substance ExposurePerfluoroalkyl SubstancesPolyfluoroalkyl Substance Exposure
Background: Per- and polyfluoroalkyl substances (PFAS), endocrine disrupting chemicals with worldwide exposure, cause changes in mammary gland development in rodents. A few human studies report delay in pubertal events with increasing perfluorooctanoic acid (PFOA) exposure, but to our knowledge none have examined reproductive hormone levels at thelarche. Methods: In a cohort of Greater Cincinnati (GC) and San Francisco Bay Area (SFBA) girls recruited at 6–8 years of age, clinical examinations were conducted annually or semiannually with sequential Tanner staging. PFAS concentrations were measured in the first serum sample of 704 girls. In 304 GC girls, estradiol (E2), estrone (E1), testosterone (T), and dihydroepiandrosterone sulfate (DHEAS) were measured in serum at four time points around puberty. Relationships between PFAS and age at thelarche, pubarche, and menarche were analyzed using survival and structural equation models. The association between PFAS and reproductive hormones was assessed using linear regression models. Results: Median PFOA serum concentrations in GC (N=353, 7.3 ng/mL) and the SFBA (N=351, 5.8 ng/mL) were higher than in the U.S. population. In multivariable Cox proportional hazard models [adjusted for race, body mass index (BMI)], increasing serum log-transformed PFOA was associated with a delay in pubarche [hazard ratio (HR)=0.83; 95% CI: 0.70, 0.99] and menarche (HR=0.04; 95% CI: 0.01, 0.25). Structural equation models indicated a triangular relationship between PFOA, BMI percentile, and the age at the pubertal milestone. Increased PFOA had a statistically significant direct effect of delay on all three milestones, as did BMI. Perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDeA), and 2-(N-methyl-perfluorooctane sulfonamido) acetic acid (Me-PFOSA-AcOH) also were associated with later thelarche, and Me-PFOSA-AcOH also with later pubarche. PFOA was inversely associated with DHEAS (p<0.01), E1 (p=0.04), and T (p=0.03) concentrations at 6 months prior to puberty. Conclusions: PFAS may delay pubertal onset through the intervening effects on BMI and reproductive hormones. The decreases in DHEAS and E1 associated with PFOA represent biological biomarkers of effect consistent with the delay in onset of puberty. https://doi.org/10.1289/EHP11811
45
Variations in pattern of pubertal changes in girls.
W. A. Marshall, J. M. Tanner · Archives of Disease in Childhood · 1969 · 5.9K citations · Full text
Medicine, Endocrinology, Pediatrics +12
The Diagnosis of Polycystic Ovary Syndrome during Adolescence
Selma F. Witchel, Sharon E. Oberfield, Robert L. Rosenfield et al. · Hormone Research in Paediatrics · 2015 · 3.1K citations · Full text
Medicine, Endocrinology, Pediatrics +17
An overview of the uses of per- and polyfluoroalkyl substances (PFAS)
Juliane Glüge, Martin Scheringer, Ian T. Cousins et al. · Environmental Science Processes & Impacts · 2020 · 2.2K citations · Full text
Pharmacy, Chemistry, Toxicology +7
Antonia M. Calafat, Lee-Yang Wong, Zsuzsanna Kuklenyik et al. · Environmental Health Perspectives · 2007 · 1.2K citations · Full text